天疱疮合并症的研究进展

[1]

WANG Yue, YAN Yulin. Analysis of risk factors for pemghigus vulgaris combined with acute pulmonary embolism [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(9): 568-570.

[2]

YAO Xiangjun, ZHANG Qi, WANG Ting, FAN Min, LUO Zhen, WANG Peiguang, WANG Zaixing. Clinical features and etiological analysis of skin infection in 656 hospitalized patients with autoimmune bullous disease [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 494-498.

[3]

GUO Xinyun, WU Huihui, CHEN Lei, SUN Wenqi, FAN Chongshuai. Pemphigus vulgaris treated with oral tacrolimus combined with glucocorticoid: a case report [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(8): 531-533.

[4]

FENG Xiaoran, LI Mengmeng, LI Jingyi, XUE Li. Minocycline hydrochloride combined with glucocorticoid in the treatment of herpetiform pemphigus: a case report [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(7): 451-453.

[5]

XIE Zhimin, SHEN Xuchen, DAI Xiangnong, LI Qingqing, YE Xingdong. Update of non-desmoglein IgG autoantibodies in the pathogenesis of pemphigus vulgaris [J]. China Journal of Leprosy and Skin Diseases, 2021, 37(5): 324-327.

[6]

ZHAN Tongyin, CHEN Zerong, LAN Xiaomeng, SHRESTHA KRISTA, ZHANG Shouyue, LIU Hongjie, HU Nianfang, WANG Lian, LI Wei. Multiple autoimmune syndrome: a case report and literature review [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(2): 94-96.

[7]

YANG Baoqi, ZHANG Zhaoxia, CHEN Mingfei, WANG Na, YAN Xiaoxiao, YANG Qing, PAN Futang, WANG Guangjin, DU Donghong, WU Mei, SHI Zhongxiang, ZHANG Furen. Treatment of pemphigus with rituximab: report of six cases and literature review [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 718-721.

[8]

SUN Feifei, YANG Baoqi. Update of biological agents and bioengineering technology in treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(12): 764-768.

[9]

WANG Qian, JIANG Shui, CHEN Guanzhi, SU Lei, WANG Zongling, CHEN Hongquan, YU Bo, QIAO Xia. Investigation of depression and anxiety in the patients with psoriasis and the influence on comorbidity [J]. China Journal of Leprosy and Skin Diseases, 2020, 36(10): 584-587.

[10]

YE Shanshan, LI Yingjie, LI Hui, YAO Xiangjun, WANG Zaixing. The role of Th17 related cytokines and chemokines in pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(9): 529-532.

[11]

LI Xiuxiu, WANG Peiguang. Update of study on the treatment of pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 757-761.

[12]

SHI Yueying, FANG Bo.

Nursing care of 35 patients with severe pemphigus [J]. China Journal of Leprosy and Skin Diseases, 2017, 33(1): 48-51.

[13]

HU Fengxia, ZHANG Xiangyue, LIANG Junqin. Analysis of on pemphigus between the Uyghur and Han nationalities in Xinjiang：A hospital -based study [J]. China Journal of Leprosy and Skin Diseases, 2016, 32(9): 523-526.

[14]

DU Tiantian, YANG Baoqi, WANG Guangjin, ZHOU Guizhi, LIU Hong, ZHANG Furen. . Herpetiform pemphigus: 3 cases report [J]. China Journal of Leprosy and Skin Diseases, 2016, 32(2): 93-95.

PDF (PC)